Zonal differences in meniscus matrix turnover and cytokine response

Osteoarthritis and Cartilage

Volumn 20, Issue 1, 2012, Pages 49-59

  Fuller, E S ^a   Smith, M M ^a   Little, C B ^a   Melrose, J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ADAMTS; Aggrecanolysis; Cytokine; Meniscus; MMP; Zonal

Indexed keywords

AGGRECAN; COLLAGEN; COLLAGENASE 3; CYTOKINE; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; INTERLEUKIN 1ALPHA; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; EXPLANT; GENE EXPRESSION; GENE SEQUENCE; IMMUNE RESPONSE; KNEE MENISCUS; KNEE OSTEOARTHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; WESTERN BLOTTING;

AGGRECANS; ANIMALS; CARTILAGE, ARTICULAR; COLLAGEN; CYTOKINES; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; INTERLEUKIN-1ALPHA; MATRIX METALLOPROTEINASES; MENISCI, TIBIAL; PROTEOLYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SHEEP; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855445254     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.10.002     Document Type: Article

References (54)

1. Van Mow R.A., Chem K.Y., Kelly M.A. Structure and function relationships of the menisci of the knee. Knee Meniscus, Basic and Clinical Foundations 1992, 37-58. Raven Press, NY, New York. V.C. Mow, S. Arnoczky., D.W. Jackson (Eds.).
2. Cheung H.S. Distribution of type I, II, III and V in the pepsin solubilized collagens in bovine menisci. Connect Tissue Res 1987, 16:343-356.
3. Eyre D.R., Wu J.J. Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett 1983, 158:265-270.
4. Gao J. Immunolocalization of types I, II, and X collagen in the tibial insertion sites of the medial meniscus. Knee Surg Sports Traumatol Arthrosc 2000, 8:61-65.
5. Kambic H.E., McDevitt C.A. Spatial organization of types I and II collagen in the canine meniscus. JOrthop Res 2005, 23:142-149.
6. McDevitt C.A., Webber R.J. The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop Relat Res 1990, 8-18.
7. Chevrier A., Nelea M., Hurtig M.B., Hoemann C.D., Buschmann M.D. Meniscus structure in human, sheep, and rabbit for animal models of meniscus repair. JOrthop Res 2009, 27:1197-1203.
8. Wight T.N. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci 2008, 13:4933-4937.
9. Bode-Lesniewska B., Dours-Zimmermann M.T., Odermatt B.F., Briner J., Heitz P.U., Zimmermann D.R. Distribution of the large aggregating proteoglycan versican in adult human tissues. JHistochem Cytochem 1996, 44:303-312.
10. Hayes A.J., Smith S.M., Gibson M.A., Melrose J. Comparative immunolocalisation of the elastin fibre associated proteins fibrillin-1, LTBP2 and MAGP-1 with components of the collagenous and proteoglycan matrix of the foetal human IVD. Spine (Phila Pa 1976) 2011.
11. Smith M.M., Little C.B. Experimental models of osteoarthritis. Osteoarthritis: Diagnosis and Medical/Surgical Management 2007, 107-125. Lipincott Williams and Wilkins, Philadelphia. R.W. Moscowitz, M. Hochberg., J.A. Buckwalter, V.M. Goldberg (Eds.).
12. Boyd K.T., Myers P.T. Meniscus preservation; rationale, repair techniques and results. Knee 2003, 10:1-11.
13. Crema M.D., Guermazi A., Li L., Nogueira-Barbosa M.H., Marra M.D., Roemer F.W., et al. The association of prevalent medial meniscal pathology with cartilage loss in the medial tibiofemoral compartment over a 2-year period. Osteoarthritis Cartilage 2010, 18:336-343.
14. Hunter D.J., Zhang Y.Q., Niu J.B., Tu X., Amin S., Clancy M., et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum 2006, 54:795-801.
15. Sun Y., Mauerhan D.R., Honeycutt P.R., Kneisl J.S., Norton J.H., Hanley E.N., et al. Analysis of meniscal degeneration and meniscal gene expression. BMC Musculoskelet Disord 2010, 11:19.
16. Katsuragawa Y., Saitoh K., Tanaka N., Wake M., Ikeda Y., Furukawa H., et al. Changes of human menisci in osteoarthritic knee joints. Osteoarthritis Cartilage 2010, 18:1133-1143.
17. McCann L., Ingham E., Jin Z., Fisher J. Influence of the meniscus on friction and degradation of cartilage in the natural knee joint. Osteoarthritis Cartilage 2009, 17:995-1000.
18. Meunier A., Odensten M., Good L. Long-term results after primary repair or non-surgical treatment of anterior cruciate ligament rupture: a randomized study with a 15-year follow-up. Scand J Med Sci Sports 2007, 17:230-237.
19. Vaziri A., Nayeb-Hashemi H., Singh A., Tafti B.A. Influence of meniscectomy and meniscus replacement on the stress distribution in human knee joint. Ann Biomed Eng 2008, 36:1335-1344.
20. Kisiday J.D., Vanderploeg E.J., McIlwraith C.W., Grodzinsky A.J., Frisbie D.D. Mechanical injury of explants from the articulating surface of the inner meniscus. Arch Biochem Biophys 2010, 494:138-144.
21. Lemke A.K., Sandy J.D., Voigt H., Dreier R., Lee J.H., Grodzinsky A.J., et al. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also therelease of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. Cell Tissue Res 2010, 340:179-188.
22. Shin S.J., Fermor B., Weinberg J.B., Pisetsky D.S., Guilak F. Regulation of matrix turnover in meniscal explants: role of mechanical stress, interleukin-1, and nitric oxide. JAppl Physiol 2003, 95:308-313.
23. Voigt H., Lemke A.K., Mentlein R., Schunke M., Kurz B. Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity invitro. Arthritis Res Ther 2009, 11:R141.
24. Wilson C.G., Vanderploeg E.J., Zuo F., Sandy J.D., Levenston M.E. Aggrecanolysis and invitro matrix degradation in the immature bovine meniscus: mechanisms and functional implications. Arthritis Res Ther 2009, 11:R173.
25. Upton M.L., Chen J., Setton L.A. Region-specific constitutive gene expression in the adult porcine meniscus. JOrthop Res 2006, 24:1562-1570.
26. Wildey G.M., Billetz A.C., Matyas J.R., Adams M.E., McDevitt C.A. Absolute concentrations of mRNA for type I and type VI collagen in the canine meniscus in normal and ACL-deficient knee joints obtained by RNase protection assay. JOrthop Res 2001, 19:650-658.
27. Mauck R.L., Martinez-Diaz G.J., Yuan X., Tuan R.S. Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Anat Rec (Hoboken) 2007, 290:48-58.
28. Melrose J., Smith S., Cake M., Read R., Whitelock J. Spatial and temporal immunolocalisation of perlecan in the ovine meniscus. Histochem Cell Biol 2005, 124:225-235.
29. Melrose J., Smith S.M., Smith M.M., Little C.B. The use of Histochoice for histological examination of articular and growth plate cartilages, intervertebral disc and meniscus. Biotech Histochem 2008, 83:47-53.
30. Smith S.M., Shu C., Melrose J. Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker. Histochem Cell Biol 2010, 134:251-263.
31. Hyde G., Boot-Handford R.P., Wallis G.A. Col2a1 lineage tracing reveals that the meniscus of the knee joint has a complex cellular origin. JAnat 2008, 213:531-538.
32. Farndale R.W., Sayers C.A., Barrett A.J. Adirect spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982, 9:247-248.
33. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967, 18:267-273.
34. Smith M.M., Sakurai G., Smith S.M., Young A.A., Melrose J., Stewart C.M., et al. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis Rheum 2008, 58:1055-1066.
35. Melrose J., Fuller E.S., Roughley P.J., Smith M.M., Kerr B., Hughes C.E., et al. Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues. Arthritis Res Ther 2008, 10:R79.
36. Collins-Racie L.A., Flannery C.R., Zeng W., Corcoran C., Annis-Freeman B., Agostino M.J., et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004, 23:219-230.
37. Fosang A.J., Last K., Stanton H., Golub S.B., Little C.B., Brown L., et al. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. Methods Mol Biol 2010, 622:312-347.
38. Milz S., Benjamin M., Putz R. Molecular parameters indicating adaptation to mechanical stress in fibrous connective tissue. Adv Anat Embryol Cell Biol 2005, 178:1-71.
39. Kenagy R.D., Min S.K., Clowes A.W., Sandy J.D. Cell death-associated ADAMTS4 and versican degradation in vascular tissue. JHistochem Cytochem 2009, 57:889-897.
40. Kern C.B., Twal W.O., Mjaatvedt C.H., Fairey S.E., Toole B.P., Iruela-Arispe M.L., et al. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 2006, 235:2238-2247.
41. McCulloch D.R., Nelson C.M., Dixon L.J., Silver D.L., Wylie J.D., Lindner V., et al. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell 2009, 17:687-698.
42. Sandy J.D., Westling J., Kenagy R.D., Iruela-Arispe M.L., Verscharen C., Rodriguez-Mazaneque J.C., et al. Versican V1 proteolysis in human aorta invivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. JBiol Chem 2001, 276:13372-13378.
43. Rogerson F.M., Chung Y.M., Deutscher M.E., Last K., Fosang A.J. Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice. Arthritis Rheum 2010, 62:3365-3373.
44. Bondeson J., Blom A.B., Wainwright S., Hughes C., Caterson B., vanden Berg W.B. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
45. Fosang A.J., Last K., Gardiner P., Jackson D.C., Brown L. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem J 1995, 310(Pt 1):337-343.
46. Fosang A.J., Last K., Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. JClin Invest 1996, 98:2292-2299.
47. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., Lohmander L.S. Human osteoarthritis synovial fluid and jointcartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 2006, 14:101-113.
48. Abramson S.B., Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009, 11:227.
49. Felson D.T. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11:203.
50. Bluteau G., Conrozier T., Mathieu P., Vignon E., Herbage D., Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 2001, 1526:147-158.
51. Hellio Le Graverand M.P., Vignon E., Otterness I.G., Hart D.A. Early changes in lapine menisci during osteoarthritis development: part II: molecular alterations. Osteoarthritis Cartilage 2001, 9:65-72.
52. Hellio Le Graverand M.P., Vignon E., Otterness I.G., Hart D.A. Early changes in lapine menisci during osteoarthritis development: part I: cellular and matrix alterations. Osteoarthritis Cartilage 2001, 9:56-64.
53. Tang Z., Yang L., Zhang J., Xue R., Wang Y., Chen P.C., et al. Coordinated expression of MMPs and TIMPs in rat knee intra-articular tissues after ACL injury. Connect Tissue Res 2009, 50:315-322.
54. Zreiqat H., Belluoccio D., Smith M.M., Wilson R., Rowley L., Jones K., et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther 2010, 12(1):R16.